Jiasheng Fu
Inventor
Stats
- 11 US patents issued
- 22 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 11 US Patents Issued
- 22 US Applications Filed
- 137 Total Citation Count
- Sep 30, 2024 Most Recent Filing
- Jul 18, 2005 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CHINA UNIVERSITY OF PETROLEUM - BEIJING (CUPB) | 2
| 2012
|
AMGEN INC. | 2
2 2 2 1 2 1 2 2 1 | 2005
2006 2008 2009 2011 2012 2013 2014 2016 2017 |
College of Petroleum Engineering, China University of Petroleum-Beijing (CUPB) | 1
| 2012
|
Inventor Addresses
Address | Duration |
---|---|
Beijing, CN | Aug 08, 13 - Aug 25, 15 |
Foster City, CA | Mar 02, 06 - Mar 29, 07 |
Foster City, CA, US | Mar 09, 10 - Sep 12, 24 |
GuangZhou, CN | Jan 21, 25 - Jan 28, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
D1059433 | 2025 | Freezer organizer bin | 0 |
D1058617 | 2025 | Freezer organizer bin | 1 |
2024/0300,892 | 2024 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | 0 |
2023/0052,348 | 2023 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | 0 |
2022/0169,611 | 2022 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.